| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), NERV's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Luthringer Remy | CEO | Sell | 27,394 | $3.84 | $105,139.21 | -28.4% | +107.2% | -47.7% | |
| May 1, 2023 | Race Geoff | President | Sell | 22,082 | $3.85 | $85,015.70 | -30.1% | +152.9% | -37.2% | |
| May 1, 2023 | Ahlholm Frederick W | SVP, CFO and Secretary | Sell | 3,580 | $4.48 | $16,038.40 | -17.0% | +152.9% | -37.2% | |
| Dec 1, 2021 | Kupfer David | Director | Sell | 55,635 | $0.88 | $48,958.80 | -25.4% | -23.7% | -50.4% | |
| Dec 16, 2020 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 1,845 | $2.64 | $4,870.80 | -15.5% | - | - | |
| Dec 16, 2020 | Luthringer Remy | CEO | Sale+OE | 1,300 | $2.64 | $3,432.00 | -1.9% | - | - | |
| Dec 16, 2020 | Race Geoff | EVP, CFO &Cbo | Sale+OE | 6,190 | $2.64 | $16,341.60 | -2.8% | - | - | |
| Dec 16, 2020 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 3,228 | $2.64 | $8,521.92 | -9.2% | - | - | |
| Sep 10, 2020 | Van Heek G Jan | Director | Buy | 7,000 | $2.97 | $20,790.00 | +52.5% | - | - | |
| May 26, 2020 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sell | 8,339 | $15.00 | $125,085.00 | -54.8% | - | - |